| ZYME |
Zymeworks Inc. |
Moore Paul Andrew |
|
2026-01-12 |
A - A |
66,000 |
0.00 |
0.00 |
66,000 |
| AKTS |
Aktis Oncology, Inc. |
NODELMAN OLEG |
Director
|
2026-01-12 |
C - A |
2,270,879 |
0.00 |
0.00 |
2,270,879 |
| AKTS |
Aktis Oncology, Inc. |
NODELMAN OLEG |
Director
|
2026-01-12 |
C - A |
202,862 |
0.00 |
0.00 |
202,862 |
| AKTS |
Aktis Oncology, Inc. |
NODELMAN OLEG |
Director
|
2026-01-12 |
C - A |
128,506 |
0.00 |
0.00 |
128,506 |
| AKTS |
Aktis Oncology, Inc. |
NODELMAN OLEG |
Director
|
2026-01-12 |
P - A |
2,077,779 |
18.00 |
37,400,022.00 |
4,348,658 |
| AKTS |
Aktis Oncology, Inc. |
NODELMAN OLEG |
Director
|
2026-01-12 |
P - A |
144,443 |
18.00 |
2,599,974.00 |
347,305 |
| AKTS |
Aktis Oncology, Inc. |
NODELMAN OLEG |
Director
|
2026-01-12 |
C - D |
9,913,810 |
0.00 |
0.00 |
0 |
| AKTS |
Aktis Oncology, Inc. |
NODELMAN OLEG |
Director
|
2026-01-12 |
C - D |
997,299 |
0.00 |
0.00 |
0 |
| AKTS |
Aktis Oncology, Inc. |
NODELMAN OLEG |
Director
|
2026-01-12 |
C - D |
488,891 |
0.00 |
0.00 |
0 |
| AKTS |
Aktis Oncology, Inc. |
NODELMAN OLEG |
Director
|
2026-01-12 |
C - D |
2,397,500 |
0.00 |
0.00 |
0 |
| AKTS |
Aktis Oncology, Inc. |
NODELMAN OLEG |
Director
|
2026-01-12 |
C - D |
102,500 |
0.00 |
0.00 |
0 |
| AKTS |
Aktis Oncology, Inc. |
NODELMAN OLEG |
Director
|
2026-01-12 |
C - A |
965,190 |
0.00 |
0.00 |
965,190 |
| AKTS |
Aktis Oncology, Inc. |
NODELMAN OLEG |
Director
|
2026-01-12 |
C - A |
86,222 |
0.00 |
0.00 |
86,222 |
| NTSK |
Netskope Inc |
Bousquet Raphael |
|
2026-01-12 |
C - A |
3,823 |
0.00 |
0.00 |
3,823 |
| NTSK |
Netskope Inc |
Bousquet Raphael |
|
2026-01-12 |
S - D |
3,823 |
16.66 |
63,680.48 |
0 |
| NTSK |
Netskope Inc |
Bousquet Raphael |
|
2026-01-12 |
C - D |
3,823 |
0.00 |
0.00 |
112,342 |
| ZYME |
Zymeworks Inc. |
Neu Kelvin |
|
2026-01-12 |
A - A |
11,500 |
0.00 |
0.00 |
11,500 |
| ZYME |
Zymeworks Inc. |
Neu Kelvin |
|
2026-01-12 |
A - A |
7,700 |
0.00 |
0.00 |
7,700 |
| NYC |
American Strategic Investment Co. |
New York City Advisors, LLC |
10% Owner
|
2026-01-12 |
P - A |
1,224 |
9.25 |
11,322.00 |
1,056,936 |
| NYC |
American Strategic Investment Co. |
New York City Advisors, LLC |
10% Owner
|
2026-01-12 |
P - A |
1,224 |
9.25 |
11,322.00 |
1,056,936 |
| ABOS |
Acumen Pharmaceuticals, Inc. |
OConnell Daniel Joseph |
Director
Officer
|
2026-01-12 |
S - D |
5,388 |
1.73 |
9,306.69 |
593,510 |
| PTCT |
PTC THERAPEUTICS, INC. |
Pauwels Eric |
|
2026-01-12 |
S - D |
1,024 |
78.70 |
80,588.80 |
80,141 |
| PCYO |
PURE CYCLE CORP |
HARDING MARK W |
|
2026-01-12 |
G - D |
210,000 |
0.00 |
0.00 |
0 |
| PTCT |
PTC THERAPEUTICS, INC. |
Pauwels Eric |
|
2026-01-12 |
S - D |
1,024 |
78.70 |
80,588.80 |
80,141 |
| MKTX |
MARKETAXESS HOLDINGS INC |
Pintoff Scott |
|
2026-01-12 |
S - D |
100 |
168.63 |
16,863.00 |
9,638 |